XT
NRXS icon

XTX Topco’s Neuraxis NRXS Stock Holding History

XTX Topco’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,068
Closed -$54.8K – 4195
2025
Q4 		$54.8K Sell
12,068
-13,328
-52% -$39.8K ﹤0.01% 2807
2025
Q3 		$78.2K Buy
+25,396
New +$64.7K ﹤0.01% 2077

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $142M AUM 161.26% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

XTX Topco's NRXS Position: Q1 2026 in Review

XTX Topco sold out of Neuraxis (NRXS) in Q1 2026, closing a stake of 12,068 shares — an estimated $54.8K sold.

XTX Topco first reported a position in NRXS in Q3 2025 and held it in 2 quarters. The position peaked at $78.2K in Q3 2025. 26 funds tracked by Wall St. Rank hold NRXS as of Q1 2026.

  • XTX Topco reported no remaining Neuraxis position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 12,068 Neuraxis shares in Q1 2026, an estimated $54.8K.
  • XTX Topco first reported a position in Neuraxis in Q3 2025 and held it in 2 quarters.
  • XTX Topco's Neuraxis position peaked at $78.2K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held Neuraxis as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.